BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates

BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to break-even earnings per share a year ago.

06.08.2026

BioLife Solutions Reports Second Quarter 2026 Financial Results

Total revenue of $28.5 million, up 21% over Q2 2025 GAAP gross margin of 64% and non-GAAP adjusted gross margin of 65% GAAP net income of $45.1 million, inclusive of a $42.4 million non-cash income tax benefit, and non-GAAP adjusted EBITDA of $7.4 million, or 26% of revenue Repligen to acquire BioLife and the proposed transaction is expected to close in the fourth quarter of 2026 BOTHELL, Wash., Aug. 6, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, announces financial results for the three and six months ended June 30, 2026.

05.08.2026

Diamond Hill Small Cap Fund Q2 2026 Portfolio Activity

Astrana Health outperformed as the company results have continued to demonstrate that it was not taking advantage of loopholes within Medicare coding. Magnolia Oil & Gas saw shares decline after an agreement was reached to end the war between the US and Iran and reopen the Strait of Hormuz. We initiated a position in Insteel Industries, the nation's largest manufacturer of steel wire reinforcing products for concrete construction.

Видео

No Data

There is no data to display

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
BLFS	The Benchmark Company	Hold	undefined >> undefined	August 10th 2026

Пресс-релизы

06.08.2026

BioLife Solutions, Inc. (BLFS)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

BioLife Solutions, Inc. (BLFS)

BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates

BioLife Solutions Reports Second Quarter 2026 Financial Results

Diamond Hill Small Cap Fund Q2 2026 Portfolio Activity

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

BioLife Solutions Reports Second Quarter 2026 Financial Results

Search stocks

BioLife Solutions, Inc. (BLFS)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

BioLife Solutions, Inc. (BLFS)

BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates

BioLife Solutions Reports Second Quarter 2026 Financial Results

Diamond Hill Small Cap Fund Q2 2026 Portfolio Activity

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

BioLife Solutions Reports Second Quarter 2026 Financial Results